Acadia Pharmaceuticals to Present at the Jefferies Global Healthcare C...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 23, 2024

AndHealth Partners with PrimaryOne Health to Address Health Inequities by Offering In-House Specialty Care • Brookdale Announces Date of First Quarter 2024 Earnings Release and Conference Call • Minister Hajdu in Vancouver to highlight budget 2024 investments in reconciliation • Gateway First Bank Receives National Certification by Banking Advocates as Offering a Safe, Affordable Personal Checking Account • AccountTECH unveils revolutionary Cloud-Based Enterprise Accounting software at the T3 Leadership Summit • 9-Time GRAMMY® Winner Sheryl Crow and Sens. John Cornyn and Amy Klobuchar to Be Honored at the GRAMMYs on the Hill® Awar • Tesla Releases First Quarter 2024 Financial Results • Forbes Magazine Recognizes RTI International As One Of The Best Employers For Diversity • American Foundation for Suicide Prevention Statement on the Release of the 2024 National Strategy for Suicide Prevention • Houston Will Host 2025 ACHE Congress Bringing More than 5,000 Healthcare Leaders to City • TELUS Health 2024 Drug Trends Report: Diabetes medications maintain top reimbursed expense position; ADHD drugs surge • Summer Health Announces Series A Fundraise from 7wireVentures and Lux Capital • Nerdy to Announce First Quarter 2024 Results on May 7, 2024 • HGreg Joins Forces With Tree Canada for an 8th Consecutive Year • Northeast Delta HSA collaborates with AKA chapter for Earth Day, plants tree to symbolize RISE Center • Popilush Introduces Bluetag COOLING Collection with Body-Cooling Technology • AudioEye Reports Record First Quarter 2024 Results • PENN Entertainment Publishes 2023 Corporate Social Responsibility Report • 5 Things to Know About First-Ever Starbucks Promises Day • New LegalShield Data: Consumer Stress in Swing States Currently Suggests a Democratic Win in November

Acadia Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

SAN DIEGO , June 01 /Businesswire/ - Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Jefferies Global Healthcare Conference on Wednesday, June 7, 2023 at 10:00 a.m. Eastern Time in New York, NY.

A live webcast of the presentation will be accessible on the company’s website, www.acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For almost 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia.com and follow us on LinkedIn and Twitter.